Based on our results demonstrating that FXR activation may counteract tumor-promoting ability of CAFs in vitro, we used mouse xenograft models to examine the effect of GW4064 on breast cancer growth in vivo. This evidence concerns the gene NR1H4 and breast carcinoma.